Related Experiment Videos
Development of HIV-1 dependent gene expression vector with the Cre/loxP (ON) system
Takashi Nagawa1, Yuichiro Habu, Norihiko Matsumoto
1Department of Industrial Chemistry, Chiba Institute of Technology, 2-17-1 Tsudanuma, Narashino, Chiba 275-0016, Japan.
Nucleic Acids Research. Supplement (2001)
|August 9, 2003
Summary
Researchers developed a novel anti-gene expression system using the HIV-1 5'LTR and Cre/loxP system. This system targets HIV-1 gene expression for potential antiviral strategies.
Area of Science:
- Molecular Biology
- Virology
- Gene Therapy
Background:
- The human immunodeficiency virus type 1 (HIV-1) long terminal repeat (LTR) promoter exhibits specific regulatory activities.
- Previous research indicated the LTR promoter's involvement with the gag gene's intermediary region.
- The Cre/loxP system offers a tool for targeted genetic manipulation.
Purpose of the Study:
- To develop a novel anti-gene expression system for HIV-1.
- To utilize the HIV-1 5'LTR and Cre/loxP system for targeted gene inhibition.
- To investigate ribozyme-mediated inhibition of HIV-1 gene expression.
Main Methods:
- Constructed a ribozyme expression vector (pCre/loxP-Rz) targeting the U5-region of HIV-1.
- Placed the Cre/loxP system under the control of the HIV-1 LTR promoter.
- Introduced the vector into HeLa-CD4+ cells in the presence of pNL4-3.
Main Results:
- The developed vector demonstrated HIV-1 dependent ribozyme-mediated inhibition.
- Inhibition occurred in a dose-responsive manner.
- Ribozyme mRNA expression was successfully detected in treated cells.
Conclusions:
- The novel anti-gene expression system effectively targets HIV-1.
- The system shows promise for developing new antiviral strategies against HIV-1.
- Further research may lead to practical applications in HIV-1 therapy.